These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 35737774)

  • 1. HIV prevention tool is too slow to reach Africa, activists say.
    Green A
    Science; 2022 Jun; 376(6600):1368-1369. PubMed ID: 35737774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention.
    Ngure K; Mugo NR; Bukusi EA; Kiptinness C; Oware K; Gakuo S; Musinguzi N; Pyra M; Garrison L; Baeten JM; Haberer JE
    J Acquir Immune Defic Syndr; 2021 Dec; 88(4):e30-e32. PubMed ID: 34446676
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
    van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
    J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis works--it's time to deliver.
    Beyrer C; Bekker LG; Pozniak A; Barré-Sinoussi F
    Lancet; 2015 Apr; 385(9977):1482-4. PubMed ID: 25933264
    [No Abstract]   [Full Text] [Related]  

  • 5. The Path to Implementation of HIV Pre-exposure Prophylaxis for People Involved in Criminal Justice Systems.
    Brinkley-Rubinstein L; Dauria E; Tolou-Shams M; Christopoulos K; Chan PA; Beckwith CG; Parker S; Meyer J
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):93-95. PubMed ID: 29516265
    [No Abstract]   [Full Text] [Related]  

  • 6. Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).
    Tolley EE; Li S; Zangeneh SZ; Atujuna M; Musara P; Justman J; Pathak S; Bekker LG; Swaminathan S; Stanton J; Farrior J; Sista N
    J Int AIDS Soc; 2019 Oct; 22(10):e25408. PubMed ID: 31651098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting injectable for HIV approved for use in the UK.
    Kirby T
    Lancet Infect Dis; 2022 Jan; 22(1):26. PubMed ID: 34953553
    [No Abstract]   [Full Text] [Related]  

  • 8. Preexposure Prophylaxis: Adapting HIV Prevention Models to Achieve Worldwide Access.
    Landers S; Kapadia F
    Am J Public Health; 2017 Oct; 107(10):1534-1535. PubMed ID: 28902562
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-prevention program fails rape survivors in Africa, group says.
    AIDS Policy Law; 2004 Apr; 19(7):4. PubMed ID: 15124597
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-exposure prophylaxis access in federally qualified health centers across 11 United States metropolitan statistical areas.
    Tookes H; Yao K; Chueng T; Butts S; Karsner R; Duque M; Cardenas G; Feaster DJ; Doblecki-Lewis S
    Int J STD AIDS; 2019 Sep; 30(10):978-984. PubMed ID: 31284842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-African AIDS treatment movement launched.
    AIDS Treat News; 2002 Sep; (383):7-8. PubMed ID: 12765127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study.
    Smith JA; Garnett GP; Hallett TB
    J Infect Dis; 2021 Oct; 224(7):1179-1186. PubMed ID: 32492704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
    Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Donnell D; Baeten JM;
    J Int AIDS Soc; 2020 May; 23(5):e25491. PubMed ID: 32396700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
    Landovitz RJ; Grinsztejn B
    J Infect Dis; 2016 May; 213(10):1519-20. PubMed ID: 26681779
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV Pre-exposure Prophylaxis Programs Incorporating Social Applications Can Reach At-Risk Men Who Have Sex With Men for Successful Linkage to Care in Missouri, USA.
    Patel RR; Harrison LC; Patel VV; Chan PA; Mayer KH; Reno HE; Manning T
    J Assoc Nurses AIDS Care; 2017; 28(3):428-430. PubMed ID: 28216178
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
    Vickerman P; Quaife M; Kilbourne-Brook M; Mvundura M; Eakle R; Terris-Prestholt F
    BMC Infect Dis; 2020 Sep; 20(1):704. PubMed ID: 32977745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrEP and the PrEPstars.
    Morgan J
    Lancet HIV; 2018 Nov; 5(11):e616. PubMed ID: 30104178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.